Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (71-80 of 334) with videos related to

Pageof 34
Sort By:
Leukemia Research|October 15, 2010
Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cellsMichael T Brady, Jaewoo Lee, Soldano Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptideFederico Perosa, Grazia Luccarelli, Marcella Prete, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2011
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytesMichael S Leibowitz, Pedro A Andrade Filho, Soldano Ferrone, et al.
Scientific Reports|January 11, 2020
Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cellsPriyanka Sharma, Brenda Diergaarde, Soldano Ferrone, et al.
Frontiers in Neuroscience|June 11, 2021
CAR T Cell-Based Immunotherapy for the Treatment of GlioblastomaLuke Maggs, Giulia Cattaneo, Ali Emre Dal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapyChien-Chung Chang, Michael Campoli, Nicholas P Restifo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patientsTakeshi Ogino, Nobuyuki Bandoh, Tatsuya Hayashi, et al.
Cancer Biology & Therapy|December 19, 2007
Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodiesElena Signorino, Davide Brusa, Riccarda Granata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentationFabio Morandi, Emma Di Carlo, Soldano Ferrone, et al.
Cancer Treatment and Research|October 11, 2005
Mechanisms of tumor evasionMichael Campoli, Soldano Ferrone, Arnold H Zea, et al.
Pageof 34

Showing results (71-80 of 334) with videos related to

Sort By:
Pageof 34
Leukemia Research|October 15, 2010
Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cellsMichael T Brady, Jaewoo Lee, Soldano Ferrone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptideFederico Perosa, Grazia Luccarelli, Marcella Prete, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2011
Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytesMichael S Leibowitz, Pedro A Andrade Filho, Soldano Ferrone, et al.
Scientific Reports|January 11, 2020
Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cellsPriyanka Sharma, Brenda Diergaarde, Soldano Ferrone, et al.
Frontiers in Neuroscience|June 11, 2021
CAR T Cell-Based Immunotherapy for the Treatment of GlioblastomaLuke Maggs, Giulia Cattaneo, Ali Emre Dal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapyChien-Chung Chang, Michael Campoli, Nicholas P Restifo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patientsTakeshi Ogino, Nobuyuki Bandoh, Tatsuya Hayashi, et al.
Cancer Biology & Therapy|December 19, 2007
Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodiesElena Signorino, Davide Brusa, Riccarda Granata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentationFabio Morandi, Emma Di Carlo, Soldano Ferrone, et al.
Cancer Treatment and Research|October 11, 2005
Mechanisms of tumor evasionMichael Campoli, Soldano Ferrone, Arnold H Zea, et al.
Pageof 34